Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 985174, 11 pages
http://dx.doi.org/10.1155/2014/985174
Research Article

Antiatherosclerotic Effect of Korean Red Ginseng Extract Involves Regulator of G-Protein Signaling 5

1Laboratory of Veterinary Physiology and Cell Signaling, College of Veterinary Medicine, Kyungpook National University, Daegu 702-701, Republic of Korea
2Department of Animal Science, College of Agriculture and Natural Resource, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia
3Laboratory of Veterinary Histology, College of Veterinary Medicine, Kyungpook National University, Daegu 702-701, Republic of Korea
4Institute of Traditional Medicine & Bioscience, Daejeon University, Daejeon 300-716, Republic of Korea
5Department of Parasitology and Tropical Medicine, Kyungpook National University School of Medicine, Daegu 700-422, Republic of Korea
6Department of Clinical Laboratory Science, Chungbuk Health & Science University, Chungbuk 363-794, Republic of Korea
7Research Center, Dongnam Institute of Radiological and Medical Sciences, Busan 619-953, Republic of Korea

Received 15 July 2014; Revised 13 November 2014; Accepted 20 November 2014; Published 24 December 2014

Academic Editor: Chong-Zhi Wang

Copyright © 2014 Eun Ju Im et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Eapen, G. L. Kalra, N. Merchant, A. Arora, and B. V. Khan, “Metabolic syndrome and cardiovascular disease in South Asians,” Vascular Health and Risk Management, vol. 5, pp. 731–743, 2009. View at Google Scholar · View at Scopus
  2. D. K. Arnett, R. L. McClelland, A. Bank et al., “Biomarkers of inflammation and hemostasis associated with left ventricular mass: the multiethnic study of atherosclerosis (MESA),” International Journal of Molecular Epidemiology and Genetics, vol. 2, no. 4, pp. 391–400, 2011. View at Google Scholar · View at Scopus
  3. X. Arzuaga, G. Reiterer, Z. Majkova, M. W. Kilgore, M. Toborek, and B. Hennig, “PPARα ligands reduce PCB-induced endothelial activation: possible interactions in inflammation and atherosclerosis,” Cardiovascular Toxicology, vol. 7, no. 4, pp. 264–272, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. P. Choudhury, J. X. Rong, E. Trogan et al., “High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 10, pp. 1904–1909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Hobson, A. Holden, and J. Meara, “Measuring the impact of Parkinson's disease with the Parkinson's disease quality of life questionnaire,” Age and Ageing, vol. 28, no. 4, pp. 341–346, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Schrag, M. Jahanshahi, and N. Quinn, “What contributes to quality of life in patients with Parkinson's disease?” Journal of Neurology, Neurosurgery & Psychiatry, vol. 69, no. 3, pp. 308–312, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Basta, A. M. Schmidt, and R. de Caterina, “Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes,” Cardiovascular Research, vol. 63, no. 4, pp. 582–592, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Lusis, “Atherosclerosis,” Nature, vol. 407, no. 6801, pp. 233–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Weber and H. Noels, “Atherosclerosis: current pathogenesis and therapeutic options,” Nature Medicine, vol. 17, no. 11, pp. 1410–1422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Mangge, G. Almer, M. Truschnig-Wilders, A. Schmidt, R. Gasser, and D. Fuchs, “Inflammation, adiponectin, obesity and cardiovascular risk,” Current Medicinal Chemistry, vol. 17, no. 36, pp. 4511–4520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. H. Karlsen, J. P. Larsen, E. Tandberg, and J. G. Mæland, “Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 66, no. 4, pp. 431–435, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Jiang, L.-Z. Xia, Y. Li, X. Li, and J. Wu, “Effect of Panax notoginseng saponins on expressions of MMP-13 and TIMP-1 in rats with hepatic fibrosis,” Zhongguo Zhong Yao Za Zhi, vol. 38, no. 8, pp. 1206–1210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-Q. Fu, C. Hua, J. Zhou, B.-R. Cheng, and J. Zhang, “Protective effects of ginseng total saponins against hepatic ischemia/reperfusion injury in experimental obstructive jaundice rats,” Pharmaceutical Biology, vol. 51, no. 12, pp. 1545–1551, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. D. H. Kim, J. H. Chung, J. S. Yoon et al., “Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-κB in LPS-stimulated RAW264.7 cells and mouse liver,” Journal of Ginseng Research, vol. 37, no. 1, pp. 54–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. J. Nah, J. H. Hahn, S. Chung, S. Choi, Y. I. Kim, and S. Y. Nah, “Effect of ginsenosides, active components of ginseng, on capsaicin-induced pain-related behavior,” Neuropharmacology, vol. 39, no. 11, pp. 2180–2184, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. T. G. Kirchgessner, K. T. Uysal, S. M. Wiesbrock, M. W. Marino, and G. S. Hotamisligil, “Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes,” The Journal of Clinical Investigation, vol. 100, no. 11, pp. 2777–2782, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. Trujillo, S. Sullivan, I. Harten, S. H. Schneider, A. S. Greenberg, and S. K. Fried, “Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5577–5582, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Beltowski, “Leptin and atherosclerosis,” Atherosclerosis, vol. 189, no. 1, pp. 47–60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ekmekci and O. B. Ekmekci, “The role of adiponectin in atherosclerosis and thrombosis,” Clinical and Applied Thrombosis/Hemostasis, vol. 12, no. 2, pp. 163–168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Holobotovskyy, M. Manzur, M. Tare et al., “Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling,” Circulation Research, vol. 112, no. 5, pp. 781–791, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. P. G. Mcgovern, J. S. Pankow, E. Shahar et al., “Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors,” The New England Journal of Medicine, vol. 334, no. 14, pp. 884–890, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. R. Jin, J. Y. Yu, J. J. Lee et al., “Antithrombotic and antiplatelet activities of Korean red ginseng extract,” Basic & Clinical Pharmacology & Toxicology, vol. 100, no. 3, pp. 170–175, 2007. View at Publisher · View at Google Scholar
  23. Y.-S. Keum, K.-K. Park, J.-M. Lee et al., “Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng,” Cancer Letters, vol. 150, no. 1, pp. 41–48, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-S. Park, E.-M. Park, D.-H. Kim et al., “Anti-inflammatory mechanism of ginseng saponins in activated microglia,” Journal of Neuroimmunology, vol. 209, no. 1-2, pp. 40–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Peto, C. Jenkinson, and R. Fitzpatrick, “PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures,” Journal of Neurology, vol. 245, supplement 1, pp. S10–S14, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. N.-I. Baek, D. S. Kim, Y. H. Lee, J. D. Park, C. B. Lee, and S. I. Kim, “Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng,” Planta Medica, vol. 62, no. 1, pp. 86–87, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Manduteanu and M. Simionescu, “Inflammation in atherosclerosis: a cause or a result of vascular disorders?” Journal of Cellular and Molecular Medicine, vol. 16, no. 9, pp. 1978–1990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Meyer-Sabellek and H. Brasch, “Atherosclerosis, inflammation, leukocyte function and the effect of statins,” Journal of Hypertension, vol. 24, no. 12, pp. 2349–2351, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. P. S. Mullenix, C. A. Andersen, and B. W. Starnes, “Atherosclerosis as inflammation,” Annals of Vascular Surgery, vol. 19, no. 1, pp. 130–138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Endale, E. J. Im, J. Y. Lee et al., “Korean red ginseng saponin fraction rich in ginsenoside-Rb1, Rc and Rb2 attenuates the severity of mouse collagen-induced arthritis,” Mediators of Inflammation, vol. 2014, Article ID 748964, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Yayeh, K.-H. Jung, H. Y. Jeong et al., “Korean red ginseng saponin fraction downregulates proinfl ammatory mediators in LPS stimulated RAW264.7 cells and protects mice against endotoxic shock,” Journal of Ginseng Research, vol. 36, no. 3, pp. 263–269, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y.-S. Kwak, J.-S. Kyung, J. S. Kim, J. Y. Cho, and M.-H. Rhee, “Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng,” Biological & Pharmaceutical Bulletin, vol. 33, no. 3, pp. 468–472, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Gawaz, H. Langer, and A. E. May, “Platelets in inflammation and atherogenesis,” The Journal of Clinical Investigation, vol. 115, no. 12, pp. 3378–3384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Endale, W. M. Lee, S. M. Kamruzzaman et al., “Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation,” British Journal of Pharmacology, vol. 167, no. 1, pp. 109–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. W. M. Lee, S. D. Kim, M. H. Park et al., “Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP,” Journal of Pharmacy and Pharmacology, vol. 60, no. 11, pp. 1531–1536, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Hollinger and J. R. Hepler, “Cellular regulation of RGS proteins: modulators and integrators of G protein signaling,” Pharmacological Reviews, vol. 54, no. 3, pp. 527–559, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Li, L. D. Adams, X. Wang et al., “Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque,” Journal of Vascular Surgery, vol. 40, no. 3, pp. 519–528, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Takata, J. Liu, F. Yin et al., “PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 11, pp. 4277–4282, 2008. View at Google Scholar